Barbara Sennino

Company: 3T Biosciences

Job title: Senior Vice President, Early Development

Seminars:

Panel Discussion: Evaluating the Cell vs Bispecific Evolution to Elevate Their Respective Advantages 10:00 am

• Consolidating the clinical advances for both approaches while highlighting the next generation for each method • Comparing clinical efficacy and safety data to highlight benefits and challenges of each modality • Discussing how the impact of various targets and TCR enhancements may differ for each approach to determine priorities for future modification • Reflecting…Read more

day: Day 1

Breaking Down Solid Tumor Barriers with a Novel Bispecific T-Cell Engager Against a Novel pHLA Target 12:35 pm

• Leveraging the 3T-TRACE platform to screen TCR and TCR mimetic molecules for specific and off-target cross-reactivities • Building highly specific and safe TCRs for shared targets to effectively treat solid tumorsRead more

day: Day 1